A peptide-drug conjugate is a coordinated system in which the targeting sequence, linker, payload and release mechanism must be evaluated together.
Four coupled design elements
The peptide contributes binding or transport behavior, the linker controls spacing and release, the payload supplies the intended experimental activity and the conjugation site can alter all three. Optimizing one component in isolation can misrepresent the complete conjugate.
Linker stability and release
Cleavable linkers respond to an enzyme, pH or chemical environment, while noncleavable designs rely on processing of the carrier. Plasma stability and target-compartment release should be measured separately because premature and incomplete release are different failure modes.
Characterizing the final construct
Identity, conjugation site, free payload, related peptide species, aggregation and functional binding all affect interpretation. Results from the unconjugated peptide or payload cannot substitute for direct testing of the conjugate.
